LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 2 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 2. - Dataset (ID:20310)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
---|---|---|---|---|---|---|---|---|---|---|
MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 27.89 | 21.74 | 490 | 1677 | 0.2922 | 0.6436 | MN20160310_N01 | H12 |
MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 27.89 | 21.74 | 1393 | 1677 | 0.8307 | 0.9417 | MN20160310_N01 | H12 |
MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 27.89 | 21.74 | 1271 | 1677 | 0.7579 | 0.9135 | MN20160310_N01 | L08 |
MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 27.89 | 21.74 | 1353 | 1677 | 0.8068 | 0.9327 | MN20160310_N01 | L08 |
MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 29.86 | 21.74 | 1002 | 1887 | 0.5310 | 0.8128 | MN20160310_N01 | G09 |
MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 29.86 | 21.74 | 1467 | 1887 | 0.7774 | 0.9233 | MN20160310_N01 | G09 |
MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 29.86 | 21.74 | 1028 | 1887 | 0.5448 | 0.8200 | MN20160310_N01 | H12 |
MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 29.86 | 21.74 | 1481 | 1887 | 0.7848 | 0.9262 | MN20160310_N01 | H12 |
MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 29.86 | 21.74 | 1329 | 1887 | 0.7043 | 0.8940 | MN20160310_N01 | L08 |
MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 29.86 | 21.74 | 1391 | 1887 | 0.7372 | 0.9075 | MN20160310_N01 | L08 |
MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 31.83 | 21.74 | 1123 | 2110 | 0.5322 | 0.8178 | MN20160310_N01 | G09 |
MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 31.83 | 21.74 | 1551 | 2110 | 0.7351 | 0.9089 | MN20160310_N01 | G09 |
MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 31.83 | 21.74 | 1209 | 2110 | 0.5730 | 0.8382 | MN20160310_N01 | H12 |
MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 31.83 | 21.74 | 1538 | 2110 | 0.7289 | 0.9065 | MN20160310_N01 | H12 |
MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 31.83 | 21.74 | 1481 | 2110 | 0.7019 | 0.8956 | MN20160310_N01 | L08 |
MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 31.83 | 21.74 | 1551 | 2110 | 0.7351 | 0.9089 | MN20160310_N01 | L08 |
MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 33.80 | 21.74 | 1187 | 2381 | 0.4984 | 0.8047 | MN20160310_N01 | G09 |
MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 33.80 | 21.74 | 1658 | 2381 | 0.6962 | 0.8959 | MN20160310_N01 | G09 |
MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 33.80 | 21.74 | 1419 | 2381 | 0.5958 | 0.8529 | MN20160310_N01 | H12 |
MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 33.80 | 21.74 | 1678 | 2381 | 0.7046 | 0.8993 | MN20160310_N01 | H12 |
MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 33.80 | 21.74 | 1593 | 2381 | 0.6689 | 0.8848 | MN20160310_N01 | L08 |
MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 33.80 | 21.74 | 1662 | 2381 | 0.6979 | 0.8966 | MN20160310_N01 | L08 |
MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 35.77 | 21.74 | 1182 | 2602 | 0.4541 | 0.7839 | MN20160310_N01 | G09 |
MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 35.77 | 21.74 | 1753 | 2602 | 0.6735 | 0.8887 | MN20160310_N01 | G09 |
MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 35.77 | 21.74 | 1605 | 2602 | 0.6166 | 0.8647 | MN20160310_N01 | H12 |